Waters to open laboratory with Chinese Pharmacopoeia
Pharma technology provider Waters as agreed with the Chinese Pharmacopoeia Commission (ChP) to establish a joint open laboratory to develop new pharmacopoeia standards.
Archives for July 9, 2014
CMO quality audits: necessary and beneficial to all, says consultant
A quality assurance audit is as beneficial to the CMO as it is to the sponsor selecting a third-party manufacturer, according to an ex-Merck Serono and MHRA consultant.
EMA delays policy on clinical trial data transparency
The Management Board of the EMA (European Medicines Agency) has postponed the formal adoption of its policy on publication of clinical trial data, though the agency stopped short of revealing exactly why.
India’s Cipla to invest £100m in UK R&D
Mumbai-based drugmaker Cipla has announced it will invest “up to £100m” ($171m) in drug development in the UK.
Pfizer investment an endorsement of 'podular' manufacturing, says G-CON
G-CON says a multi-million dollar investment by Pfizer could hasten the “paradigm shift” in pharma manufacturing towards flexible cleanroom technology and portable facility design.
Aesica adds roller compaction unit in growing German market
CDMO Aesica Pharmaceuticals is adding additional services to its Zwickau, Germany oral solids capabilities, including a new roller compaction unit for dry granulation production.
David and Goliath can coexist says group accusing US Pharma of anti-Indian tactics
The Indian industry group that accused US Big Pharma of anti-Indian tactics last week has said there is room for both generics firms and innovators.
Actavis cuts down Forest as $28bn acquisition closes
Actavis says it is closing facilities in St. Louis, Missouri affecting 190 jobs a week after completing the $28bn (€21bn) acquisition of Forest Laboratories.